NLRC5 and breast carcinoma: The relative levels of NLRC5 in SKBR3 breast cancer cells after 24-h treatment with IFN-γ were increased in the groups treated with 50 U/ml and 100 U/ml IFN-γ, with dose dependent tendency compared with the control group with statistical significance (p < .05) (Figure 3).